Scoopfeeds — Intelligent news, curated.
Evercore ISI Retains an “Outperform Rating” on BridgeBio Pharma, Inc. (BBIO)
business

Evercore ISI Retains an “Outperform Rating” on BridgeBio Pharma, Inc. (BBIO)

Yahoo Finance · May 13, 2026, 5:53 PM

Evercore ISI Retains an “Outperform Rating” on BridgeBio Pharma, Inc. (BBIO)

Read full story on Yahoo Finance → More top stories
Aggregated and edited by the Scoop newsroom. We surface news from Yahoo Finance alongside other reporting so you can compare coverage in one place. Editorial policy · Corrections · About Scoop